Literature DB >> 12717235

Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation.

Wayel Jassem1, Dicken D H Koo, Paolo Muiesan, Lucia Cerundolo, Mohamed Rela, Susan V Fuggle, Nigel D Heaton.   

Abstract

BACKGROUND: Liver transplantation from non-heart-beating donors (NHBD) has been reintroduced into clinical practice to increase the donor pool; however, little is known about the immune status of NHBD livers. The aim of this study was to assess intragraft cell populations and inflammatory markers in NHBD and to compare the findings with cadaveric and living-related donor (LRD) livers.
METHODS: Biopsy specimens were obtained from controlled NHBD (n=9), conventional cadaveric (n=22), and living-donor (n=10) livers at the end of cold storage. Cryostat sections were stained for monocytes-macrophages, T lymphocytes, and intercellular adhesion molecule (ICAM)-1.
RESULTS: The levels of leukocyte infiltration in NHBD reflected those found in conventional cadaver donors and were significantly higher than in LRD livers. Similar levels of CD68+ monocytes-macrophages were detected in cadaver (4.0+/-1.2%) and NHBD livers (4.6+/-1.2%) and were significantly greater than in the LRD livers (2.6+/-0.5%, P<0.01). Furthermore, the levels of T lymphocytes in NHBD (1.1+/-0.6%) and cadaver donors (1.5+/-0.8%) were similar, and were higher than in LRD (vs. 0.47+/-0.3%, P<0.05). Twelve of 22 (60%) cadaver livers had high levels of ICAM-1 expression (grade 3), compared with only 1 of 10 (10%) LRD livers (P=0.02). Four of nine (44%) controlled NHBD livers expressed high levels of ICAM-1.
CONCLUSIONS: The results demonstrate that livers obtained from controlled NHBD before transplantation are similar to conventional cadaver donors regarding the level of leukocyte infiltration. Nevertheless, lower levels of ICAM-1 were detected in NHBD, suggesting less exposure to inflammatory mediators than conventional cadaver donor livers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717235     DOI: 10.1097/01.TP.0000062863.06782.89

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

2.  Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Marlies E J Reinders; Ellen Lievers; Jan Ringers; Jan H N Lindeman; Alexander F M Schaapherder
Journal:  Inflamm Res       Date:  2012-09-13       Impact factor: 4.575

3.  Impact of Donation Mode on the Proportion and Function of T Lymphocytes in the Liver.

Authors:  Emmanuel Xystrakis; Muhammed Yuksel; Fang Lin; Xiaohong Huang; Oltin Tiberiu Pop; Alberto Quaglia; Nigel Heaton; Andreas Prachalias; Mohamed Rela; Susan Fuggle; Yun Ma; Wayel Jassem
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

4.  Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction.

Authors:  Jin Xu; Ana M Casas-Ferreira; Yun Ma; Arundhuti Sen; Min Kim; Petroula Proitsi; Maltina Shkodra; Maria Tena; Parthi Srinivasan; Nigel Heaton; Wayel Jassem; Cristina Legido-Quigley
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.